Microcarriers Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Contract Manufacturing Organizations, Academic and Research Institutes): Global Market Size Estimates and Forecast (2022-2030)

BMIRE00027060 | Pages: 100 | Biotechnology | Oct 2022 | Type: Global | Status: Published

The market is expected to cross US$ 1.98 billion mark in 2022 and is expected to hit US$ 4.32 billion by 2030, recording a CAGR of 10.3% during the forecast period. 

The demand for cell-based vaccines will drive the market's growth.

Climate change, population growth, and increasing contact between humans and animals have increased the threat of new virus outbreaks. For example, COVID- 19. Cell culture is increasingly becoming an important part of vaccine production in the pharmaceutical industry. Earlier, vaccines were manufactured by growing and harvesting viruses in chicken eggs, which is a time-consuming process. On the other hand, cell-based vaccine production has emerged as an efficient method due to its shortened lead time and the capability to produce vaccines in larger quantities. In addition to these benefits, clinical trials have proved that cell-based vaccines are effective, safe, and productive. For instance, in Aug 2022, Cytiva, a company of Danaher Corporation, and Caring Cross, a non-profit organization, agreed to contribute their expertise to develop CAR-T cell therapy for people with HIV.

Within the report, the market is segmented into product, application, end-user, and geography. Based on products, the global microcarriers market is segmented into consumables and equipment. The consumables segment is sub-segmented into media, reagents, and microcarriers. The equipment segment is sub-segmented into bioreactors, culture vessels, filtration and separation equipment, cell counters, and other equipment. Based on application, the market is categorized into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other applications. Based on end users, the market is categorized into pharmaceutical and biotechnology companies, contract research organizations & contract manufacturing organizations, and academic and research institutes. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

The surge in demand from biotechnology and pharmaceutical companies will empower the market's growth.

Cell culture is increasingly becoming an important part of vaccine production in the pharmaceutical industry. Intensified and high-performing biopharma processes have raised the bar on the requirements for fully defined and non-animal-derived cell culture media ingredients to produce therapeutic proteins or viral vectors. Evonik entered into a partnership with biopharmaceutical companies to offer high-quality cell culture solutions to help them boost cell culture performance in the manufacturing of therapeutic proteins like monoclonal antibodies, as well as in the production of viral vectors such as the adeno-associated viral (AAV) vectors for gene therapy.

Increasing R&D activities in the biotechnology industry is a standalone factor for market growth.

Growing research and development activities on new therapies such as gene and stem cells and and rising number of bipharma companies are fuelling the market growth during the forecast period. For instance, Carrousel, the microcarrier supplier for cell culture in the bioreactor, has  raised €1.5 million. The funding includes the closing of a Series A financing led by the Novalis Biotech Acceleration fund and with the participation of Crédit Agricole des Savoie (CADS), as well as support from Bpifrance. The funding is used to accelerate corporate growth through the industrialization of the company's platform technology and ramp up mass production processes to GMP standards.

Recent strategic developments in the microcarriers market

The microcarriers market has undergone several significant developments, and a few of these have been mentioned below:

  • In July 2021, Sartorius acquired cell culture specialist Xell AG. Xell AG develops, produces, and markets media and feed supplements for cell cultures, especially for manufacturing viral vectors in gene therapeutics and vaccines. 
  • In January 2021, Thermo Fisher Scientific (US0 launched a 500 L HyPerforma DynaDrive SUB designed for optimal cell culture performance.
  • In March 2020, Danaher acquired the Biopharma business from General Electric Company's Life Sciences division and renamed it Cytiva.

Several players drive the microcarriers market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Corning, Eppendorf AG, BD, Merck, ChemoMetec, CESCO Bioengineering, and HiMedia Laboratories, are among the prominent players operating in the market.

The target audience for the report:

  • Raw material providers
  • Government bodies, such as regulating authorities and policymakers
  • Venture capitalists, private equity firms, and start-up companies
  • End users
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Product:
    • Consumables
  • Media
  • Reagents
  • Microcarriers
    • Equipment
  • Bioreactors
  • Culture Vessels
  • Filtration
  • Separation Equipment
  • Cell Counters
  • Other Equipment


  • Application
    • Biopharmaceutical Production
    • Cell And Gene Therapy
    • Tissue Engineering
    • Regenerative Medicine
    • Other Applications
  • End-user:
    • Biotechnology Companies
    • Contract Research Organizations & Contract Manufacturing Organizations
    • Academic and Research Institutes
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Thermo Fisher Scientific
  • Sartorius AG
  • Danaher Corporation
  • Corning
  • Eppendorf AG
  • BD
  • Merck
  • ChemoMetec
  • CESCO Bioengineering
  • HiMedia Laboratories

The List of Companies
- Thermo Fisher Scientific
- Sartorius AG
- Danaher Corporation
- Corning
- Eppendorf AG
- BD
- Merck
- ChemoMetec
- CESCO Bioengineering
- HiMedia Laboratories

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Purchase Options
Single User License
Site License
Enterprise License